Professor Michael Heneghan is a leading consultant hepatologist, based in London. He has a specialist interest in autoimmune liver disease, cirrhosis, and liver transplantation, and new therapies for end-stage liver disease. Professor Heneghan is currently practising at his three private clinics.
After receiving his qualification in medicine from University College Dumblin, Professor Heneghan furthered his speciality education and completed his training in gastroenterology and hepatology in Ireland, London, and America. He subsequently held the position of medical director of liver transplantation at Duke University Medical Centre in North Carolina, before holding prestigious positions at top liver clinics, the London Liver Centre at London Bridge Hospital, and the Guthrie Clinic at King's College London.
Alongside his clinical work, Professor Heneghan has published numerous studies, medical articles in peer-reviewed journals, and has been involved in numerous research projects, as well as devoting time to lecturing developing future doctors. He maintains professional memberships in multiple associations and societies, but is most notably a medical advisor to the Preliminary Biliary Cirrhosis Foundation.
Professor Heneghan continues to enrich himself and the hepatology field by doing research. His interests include liver autoimmunity and innovative therapies in end-stage liver disease.